Skip to main content
/
Basilea Pharmaceutica AG (SWX:BSLN)
Switzerland flag Switzerland · Delayed Price · Currency is CHF
44.85
+0.65 (1.47%)
May 2, 2025, 5:30 PM CET

Basilea Pharmaceutica AG Revenue

In the year 2024, Basilea Pharmaceutica AG had annual revenue of 208.54M CHF with 32.30% growth. Basilea Pharmaceutica AG had revenue of 132.25M in the half year ending December 31, 2024, with 46.75% growth.

Revenue
208.54M
Revenue Growth
+32.30%
P/S Ratio
2.61
Revenue / Employee
1.27M
Employees
164
Market Cap
544.04M

Revenue Chart

Created with Highcharts 11.4.8Basilea Pharmaceutica AG Revenue - Annual127.6M​127.6M148.1M​148.1M147.8M​147.8M157.6M​157.6M208.5M​208.5M20202021202220232024-50M100M150M200M

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024208.54M50.91M32.30%
Dec 31, 2023157.63M9.87M6.68%
Dec 31, 2022147.77M-357.00K-0.24%
Dec 31, 2021148.12M20.49M16.06%
Dec 31, 2020127.63M-6.75M-5.02%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Roche Holding AG 62.40B
Novartis AG 47.01B
Lonza Group AG 6.57B
Alcon 8.98B
Galderma Group AG 4.02B
Straumann Holding AG 2.50B
Sandoz Group AG 9.41B
Sonova Holding AG 3.71B
Revenue Rankings

Basilea Pharmaceutica AG News

More News